Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR

ClinicalTrials.gov ID: NCT00574379

Public ClinicalTrials.gov record NCT00574379. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo Given Orally in The Treatment of the Symptoms of Seasonal Allergic Rhino-Conjunctivitis With Allergy to Mountain Cedar Pollen

Study identification

NCT ID
NCT00574379
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Faes Farma, S.A.
Industry
Enrollment
805 participants

Conditions and interventions

Interventions

  • Bilastine Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2007
Primary completion
Feb 29, 2008
Completion
Feb 29, 2008
Last update posted
Feb 14, 2019

2007 – 2008

United States locations

U.S. sites
13
U.S. states
2
U.S. cities
5
Facility City State ZIP Site status
Oklahoma Allergy and Asthma Clinic Oklahoma City Oklahoma 73104
MetaClin Research Inc. Austin Texas 78704
Austin Clinical Research Austin Texas 78750
Lovelace Scientific Resources Austin Texas 78759
Kerrville Research Associates Kerrville Texas 78028-6071
Biogenics Research Institute San Antonio Texas 78229
DGD Research San Antonio Texas 78229
Diagnostics Research Group San Antonio Texas 78229
Southwest Allergy and Asthma Centre San Antonio Texas 78229
Sylvana Research Associates San Antonio Texas 78229
Live Oak Allergy and Asthma San Antonio Texas 78233
Allergy & Asthma Care of Waco Waco Texas 76708
Allergy Asthma Research Institute Waco Texas 76712

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00574379, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 14, 2019 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00574379 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →